Assenagon Asset Management S.A. Biomarin Pharmaceutical Inc Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 108,972 shares of BMRN stock, worth $7.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

108,972

Previous 352,474 69.08%

Holding current value

$7.34 Million

Previous $29 Million 73.61%

% of portfolio

0.02%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$69.02 - $93.84 $16.8 Million - $22.9 Million	-243,502 Reduced 69.08%	108,972 $7.66 Million
Q2 2024 Jul 18, 2024	BUY	$74.43 - $92.22 $26 Million - $32.2 Million	349,329 Added 11107.44%	352,474 $29 Million
Q1 2024 Apr 24, 2024	SELL	$83.81 - $99.0 $1.16 Million - $1.37 Million	-13,842 Reduced 81.49%	3,145 $274,000
Q4 2023 Jan 17, 2024	SELL	$76.22 - $98.51 $6.56 Million - $8.48 Million	-86,091 Reduced 83.52%	16,987 $1.64 Million
Q3 2023 Nov 06, 2023	SELL	$85.07 - $94.48 $15.8 Million - $17.6 Million	-186,122 Reduced 64.36%	103,078 $9.12 Million
Q2 2023 Jul 25, 2023	SELL	$86.68 - $100.3 $6.9 Million - $7.98 Million	-79,548 Reduced 21.57%	289,200 $25.1 Million
Q1 2023 Apr 18, 2023	SELL	$87.74 - $117.27 $29.5 Million - $39.4 Million	-336,000 Reduced 47.68%	368,748 $35.9 Million
Q4 2022 Jan 12, 2023	BUY	$80.93 - $108.63 $25.4 Million - $34.1 Million	313,566 Added 80.16%	704,748 $72.9 Million
Q3 2022 Oct 27, 2022	BUY	$82.16 - $96.94 $12.5 Million - $14.7 Million	151,946 Added 63.51%	391,182 $33.2 Million
Q2 2022 Jul 27, 2022	BUY	$71.48 - $86.85 $13.5 Million - $16.4 Million	188,671 Added 373.13%	239,236 $19.8 Million
Q1 2022 Apr 25, 2022	SELL	$74.28 - $92.69 $5.06 Million - $6.31 Million	-68,115 Reduced 57.39%	50,565 $3.9 Million
Q4 2021 Feb 01, 2022	BUY	$71.72 - $91.47 $7.47 Million - $9.52 Million	104,127 Added 715.5%	118,680 $10.5 Million
Q3 2021 Oct 19, 2021	BUY	$74.77 - $85.47 $1.09 Million - $1.24 Million	14,553 New	14,553 $1.13 Million
Q4 2020 Feb 01, 2021	SELL	$72.61 - $90.2 $516,329 - $641,412	-7,111 Closed	0 $0
Q3 2020 Oct 07, 2020	SELL	$71.87 - $131.03 $996,477 - $1.82 Million	-13,865 Reduced 66.1%	7,111 $541,000
Q2 2020 Jul 21, 2020	BUY	$79.55 - $124.22 $539,905 - $843,081	6,787 Added 47.83%	20,976 $2.59 Million
Q1 2020 Apr 17, 2020	BUY	$71.37 - $96.85 $1.01 Million - $1.37 Million	14,189 New	14,189 $1.2 Million
Q2 2018 Jul 17, 2018	SELL	$76.01 - $99.03 $280,476 - $365,420	-3,690 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$77.67 - $92.63 $54,058 - $64,470	-696 Reduced 15.87%	3,690 $299,000
Q4 2017 Jan 25, 2018	BUY	$80.76 - $95.13 $354,213 - $417,240	4,386	4,386 $391,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Biomarin Pharmaceutical Inc Transaction History